Compare INBX & DCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INBX | DCH |
|---|---|---|
| Founded | 2010 | 1994 |
| Country | United States | United States |
| Employees | N/A | 18000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2024 | N/A |
| Metric | INBX | DCH |
|---|---|---|
| Price | $92.91 | $6.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $150.00 | $10.50 |
| AVG Volume (30 Days) | 267.1K | ★ 3.5M |
| Earning Date | 05-15-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,300,000.00 | N/A |
| Revenue This Year | N/A | $82.65 |
| Revenue Next Year | N/A | $4.20 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 550.00 | N/A |
| 52 Week Low | $13.97 | $5.07 |
| 52 Week High | $155.29 | $8.75 |
| Indicator | INBX | DCH |
|---|---|---|
| Relative Strength Index (RSI) | 43.53 | 49.80 |
| Support Level | $71.31 | $5.33 |
| Resistance Level | $94.52 | $7.20 |
| Average True Range (ATR) | 6.37 | 0.33 |
| MACD | 0.11 | -0.03 |
| Stochastic Oscillator | 38.60 | 43.27 |
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Dauch Corp is a world-wide Tier 1 Automotive Supplier, Dauch designs, engineers and manufactures Driveline and Metal Forming technologies to support electric, hybrid and internal combustion vehicles.